Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
ASTERDM
Dr. Mandayapurath Azad Moopen DTCD, M.D., MBBS · Hyderabad, India
₹814.00
▼-0.53%ASTERDM is trading near its 52-week high with strong revenue growth but elevated valuation, reflecting investor confidence in its healthcare expansion despite premium multiples.
Exchange
NSI
Currency
INR
Day range
₹811.10 – ₹839.40
52-week range
₹519.10 – ₹839.40
Sector
Healthcare
Industry
Medical Care Facilities
AI investment rating
AI analysis75% confidence
The stock appears overvalued based on its high P/E ratio of 109.41, though premium may be justified by strong revenue growth and sector positioning.
3.0% below the 1-year high · trend down
Hedge-fund memo
Today
Stock is up marginally (+0.60%) trading near its 52-week high, indicating continued bullish sentiment.
This week
The stock is holding near its recent highs, suggesting short-term strength and positive momentum.
This month
Performance over the past month has been positive with the stock approaching its 52-week peak.
Bull thesis
Bear thesis
News & sentiment
Bullish
2 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).
2.716 vs 1.6
69.75% surprise
1.3331 vs 2
-33.35% surprise
2.1351 vs 2.2
-2.95% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| ASTERDM | 712.37B | 109.41 | 10.07% | 13.98% | 18.20% |
| NH | 420.54B | 52.03 | 19.84% | 13.72% | 75.80% |
| ERIS | 197.68B | 31.56 | 18.07% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
High valuation making the stock vulnerable to corrections
Mitigation: Diversify healthcare exposure and consider partial profit booking at peaks
Regulatory changes in healthcare sector affecting profitability
Mitigation: Maintain flexibility in business model and adapt to regulatory changes
Business intelligence
Competitive moat
Strong brand recognition and established network of healthcare facilities providing competitive advantage in the Indian medical care sector.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Expansion of healthcare facility network
Earnings report showing continued revenue growth
Thesis builder
Bull case
Strong revenue growth in healthcare sector with potential for further expansion as India's healthcare needs grow
Base case
Stable performance maintaining premium valuation with moderate profit margins
Bear case
High P/E multiple could lead to significant correction if growth slows
Time horizon
Long-term (3-5 years)
Est. CAGR
15-20%
Entry (qual.)
Consider on any significant pullback below 700 INR for better risk-reward
Exit (qual.)
Monitor for sustained deceleration in revenue growth below 10% YoY
Overall conviction 75%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how ASTERDM fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain ASTERDM for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
Hidden opportunities
Watch next
The stock appears overvalued but momentum and growth prospects may justify holding for long-term investors.
scanx.trade·5d ago·rebranding to emphasize quality
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
1.7288 vs 1.65
4.78% surprise
| 27.12% |
| 7.10% |
| METROPOLIS | 122.68B | 64.37 | 13.37% | 16.51% | 23.00% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹811.10
Resistance (day/52w high)
₹839.40
Volume
6,76,774
Trend
down
RSI (14)
55
MACD
bearish
MA cross
golden
50-day MA
₹780.86
200-day MA
₹682.70
vs 200-DMA
19.2%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.